Search Browse Earnings

Ocugen, Inc. — SlamSEC

Ocugen, Inc.

Nasdaq:OCGN

Biological Products, (No Diagnostic Substances)·MALVERN, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$4.1M

-32.8% YoY

FY 2025

Adj. EBITDA

-$54.5M

-1344.7% margin

FY 2025

Net Income

-$54.1M

-1333.0% margin

FY 2025

EPS (Diluted)

-$0.09

FY 2023

Stock Price

$1.68

-3.7%

2026-03-09

52W Range

$0.52 – $2.00

P/E Ratio

-18.6x

Market Cap

$549.2M

Cash

$129.8M

FY 2023

Total Debt

$27.6M

FY 2025

Net Cash

$102.2M

FY 2025

Enterprise Value

$447.0M

Debt / EBITDA

1.9x

FY 2025

EV / EBITDA

-8.2x

Employees

—

CEO

Musunuri Shankar